Pneumococcal Vaccines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
Pneumococcal Vaccines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Pneumococcal Vaccines industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Pneumococcal Vaccines 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pneumococcal Vaccines worldwide and market share by regions, with company and product introduction, position in the Pneumococcal Vaccines market
Market status and development trend of Pneumococcal Vaccines by types and applications
Cost and profit status of Pneumococcal Vaccines, and marketing status
Market growth drivers and challenges
The report segments the global Pneumococcal Vaccines market as:
Global Pneumococcal Vaccines Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Pneumococcal Vaccines Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
PPSV 23
PCV 7/13
PCV 10
Global Pneumococcal Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
For Infants
For Children (2-10)
For Person (10-64)
For The Old (?65)
Global Pneumococcal Vaccines Market: Manufacturers Segment Analysis (Company and Product introduction, Pneumococcal Vaccines Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Pneumococcal Vaccines-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on Pneumococcal Vaccines industry, standing on the readers? perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of Pneumococcal Vaccines 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of Pneumococcal Vaccines worldwide and market share by regions, with company and product introduction, position in the Pneumococcal Vaccines market
Market status and development trend of Pneumococcal Vaccines by types and applications
Cost and profit status of Pneumococcal Vaccines, and marketing status
Market growth drivers and challenges
The report segments the global Pneumococcal Vaccines market as:
Global Pneumococcal Vaccines Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global Pneumococcal Vaccines Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
PPSV 23
PCV 7/13
PCV 10
Global Pneumococcal Vaccines Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
For Infants
For Children (2-10)
For Person (10-64)
For The Old (?65)
Global Pneumococcal Vaccines Market: Manufacturers Segment Analysis (Company and Product introduction, Pneumococcal Vaccines Sales Volume, Revenue, Price and Gross Margin):
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF PNEUMOCOCCAL VACCINES
1.1 Definition of Pneumococcal Vaccines in This Report
1.2 Commercial Types of Pneumococcal Vaccines
1.2.1 PPSV
1.2.2 PCV 7/13
1.2.3 PCV
1.3 Downstream Application of Pneumococcal Vaccines
1.3.1 For Infants
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (?65)
1.4 Development History of Pneumococcal Vaccines
1.5 Market Status and Trend of Pneumococcal Vaccines 2013-2023
1.5.1 Global Pneumococcal Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Pneumococcal Vaccines Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pneumococcal Vaccines 2013-2017
2.2 Sales Market of Pneumococcal Vaccines by Regions
2.2.1 Sales Volume of Pneumococcal Vaccines by Regions
2.2.2 Sales Value of Pneumococcal Vaccines by Regions
2.3 Production Market of Pneumococcal Vaccines by Regions
2.4 Global Market Forecast of Pneumococcal Vaccines 2018-2023
2.4.1 Global Market Forecast of Pneumococcal Vaccines 2018-2023
2.4.2 Market Forecast of Pneumococcal Vaccines by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pneumococcal Vaccines by Types
3.2 Sales Value of Pneumococcal Vaccines by Types
3.3 Market Forecast of Pneumococcal Vaccines by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pneumococcal Vaccines by Downstream Industry
4.2 Global Market Forecast of Pneumococcal Vaccines by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pneumococcal Vaccines Market Status by Countries
5.1.1 North America Pneumococcal Vaccines Sales by Countries (2013-2017)
5.1.2 North America Pneumococcal Vaccines Revenue by Countries (2013-2017)
5.1.3 United States Pneumococcal Vaccines Market Status (2013-2017)
5.1.4 Canada Pneumococcal Vaccines Market Status (2013-2017)
5.1.5 Mexico Pneumococcal Vaccines Market Status (2013-2017)
5.2 North America Pneumococcal Vaccines Market Status by Manufacturers
5.3 North America Pneumococcal Vaccines Market Status by Type (2013-2017)
5.3.1 North America Pneumococcal Vaccines Sales by Type (2013-2017)
5.3.2 North America Pneumococcal Vaccines Revenue by Type (2013-2017)
5.4 North America Pneumococcal Vaccines Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pneumococcal Vaccines Market Status by Countries
6.1.1 Europe Pneumococcal Vaccines Sales by Countries (2013-2017)
6.1.2 Europe Pneumococcal Vaccines Revenue by Countries (2013-2017)
6.1.3 Germany Pneumococcal Vaccines Market Status (2013-2017)
6.1.4 UK Pneumococcal Vaccines Market Status (2013-2017)
6.1.5 France Pneumococcal Vaccines Market Status (2013-2017)
6.1.6 Italy Pneumococcal Vaccines Market Status (2013-2017)
6.1.7 Russia Pneumococcal Vaccines Market Status (2013-2017)
6.1.8 Spain Pneumococcal Vaccines Market Status (2013-2017)
6.1.9 Benelux Pneumococcal Vaccines Market Status (2013-2017)
6.2 Europe Pneumococcal Vaccines Market Status by Manufacturers
6.3 Europe Pneumococcal Vaccines Market Status by Type (2013-2017)
6.3.1 Europe Pneumococcal Vaccines Sales by Type (2013-2017)
6.3.2 Europe Pneumococcal Vaccines Revenue by Type (2013-2017)
6.4 Europe Pneumococcal Vaccines Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pneumococcal Vaccines Market Status by Countries
7.1.1 Asia Pacific Pneumococcal Vaccines Sales by Countries (2013-2017)
7.1.2 Asia Pacific Pneumococcal Vaccines Revenue by Countries (2013-2017)
7.1.3 China Pneumococcal Vaccines Market Status (2013-2017)
7.1.4 Japan Pneumococcal Vaccines Market Status (2013-2017)
7.1.5 India Pneumococcal Vaccines Market Status (2013-2017)
7.1.6 Southeast Asia Pneumococcal Vaccines Market Status (2013-2017)
7.1.7 Australia Pneumococcal Vaccines Market Status (2013-2017)
7.2 Asia Pacific Pneumococcal Vaccines Market Status by Manufacturers
7.3 Asia Pacific Pneumococcal Vaccines Market Status by Type (2013-2017)
7.3.1 Asia Pacific Pneumococcal Vaccines Sales by Type (2013-2017)
7.3.2 Asia Pacific Pneumococcal Vaccines Revenue by Type (2013-2017)
7.4 Asia Pacific Pneumococcal Vaccines Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pneumococcal Vaccines Market Status by Countries
8.1.1 Latin America Pneumococcal Vaccines Sales by Countries (2013-2017)
8.1.2 Latin America Pneumococcal Vaccines Revenue by Countries (2013-2017)
8.1.3 Brazil Pneumococcal Vaccines Market Status (2013-2017)
8.1.4 Argentina Pneumococcal Vaccines Market Status (2013-2017)
8.1.5 Colombia Pneumococcal Vaccines Market Status (2013-2017)
8.2 Latin America Pneumococcal Vaccines Market Status by Manufacturers
8.3 Latin America Pneumococcal Vaccines Market Status by Type (2013-2017)
8.3.1 Latin America Pneumococcal Vaccines Sales by Type (2013-2017)
8.3.2 Latin America Pneumococcal Vaccines Revenue by Type (2013-2017)
8.4 Latin America Pneumococcal Vaccines Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pneumococcal Vaccines Market Status by Countries
9.1.1 Middle East and Africa Pneumococcal Vaccines Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Pneumococcal Vaccines Revenue by Countries (2013-2017)
9.1.3 Middle East Pneumococcal Vaccines Market Status (2013-2017)
9.1.4 Africa Pneumococcal Vaccines Market Status (2013-2017)
9.2 Middle East and Africa Pneumococcal Vaccines Market Status by Manufacturers
9.3 Middle East and Africa Pneumococcal Vaccines Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Pneumococcal Vaccines Sales by Type (2013-2017)
9.3.2 Middle East and Africa Pneumococcal Vaccines Revenue by Type (2013-2017)
9.4 Middle East and Africa Pneumococcal Vaccines Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PNEUMOCOCCAL VACCINES
10.1 Global Economy Situation and Trend Overview
10.2 Pneumococcal Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 11 PNEUMOCOCCAL VACCINES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pneumococcal Vaccines by Major Manufacturers
11.2 Production Value of Pneumococcal Vaccines by Major Manufacturers
11.3 Basic Information of Pneumococcal Vaccines by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pneumococcal Vaccines Major Manufacturer
11.3.2 Employees and Revenue Level of Pneumococcal Vaccines Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PNEUMOCOCCAL VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Pfizer
12.1.1 Company profile
12.1.2 Representative Pneumococcal Vaccines Product
12.1.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Pfizer
12.2 Sanofi
12.2.1 Company profile
12.2.2 Representative Pneumococcal Vaccines Product
12.2.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Sanofi
12.3 GSK
12.3.1 Company profile
12.3.2 Representative Pneumococcal Vaccines Product
12.3.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of GSK
12.4 Merck
12.4.1 Company profile
12.4.2 Representative Pneumococcal Vaccines Product
12.4.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Merck
12.5 Eli Lilly
12.5.1 Company profile
12.5.2 Representative Pneumococcal Vaccines Product
12.5.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Eli Lilly
12.6 AstraZeneca
12.6.1 Company profile
12.6.2 Representative Pneumococcal Vaccines Product
12.6.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca
12.7 Abera
12.7.1 Company profile
12.7.2 Representative Pneumococcal Vaccines Product
12.7.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Abera
12.8 S K Chemicals
12.8.1 Company profile
12.8.2 Representative Pneumococcal Vaccines Product
12.8.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of S K Chemicals
12.9 Beijing Minhai Biotechnology
12.9.1 Company profile
12.9.2 Representative Pneumococcal Vaccines Product
12.9.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Beijing Minhai Biotechnology
12.10 Baxter
12.10.1 Company profile
12.10.2 Representative Pneumococcal Vaccines Product
12.10.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Baxter
12.11 Biken
12.11.1 Company profile
12.11.2 Representative Pneumococcal Vaccines Product
12.11.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Biken
12.12 Celgene Corporation
12.12.1 Company profile
12.12.2 Representative Pneumococcal Vaccines Product
12.12.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Celgene Corporation
12.13 Panacea Biotec
12.13.1 Company profile
12.13.2 Representative Pneumococcal Vaccines Product
12.13.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Panacea Biotec
12.14 Serum Institute of India
12.14.1 Company profile
12.14.2 Representative Pneumococcal Vaccines Product
12.14.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Serum Institute of India
12.15 Genentech
12.15.1 Company profile
12.15.2 Representative Pneumococcal Vaccines Product
12.15.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Genentech
12.16 Genocea Biosciences
12.17 ImmunoBiology
12.18 Lupin
12.19 Nuron Biotech
12.20 Biogen
12.21 Valneva Austria
12.22 Sinovac
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PNEUMOCOCCAL VACCINES
13.1 Industry Chain of Pneumococcal Vaccines
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PNEUMOCOCCAL VACCINES
14.1 Cost Structure Analysis of Pneumococcal Vaccines
14.2 Raw Materials Cost Analysis of Pneumococcal Vaccines
14.3 Labor Cost Analysis of Pneumococcal Vaccines
14.4 Manufacturing Expenses Analysis of Pneumococcal Vaccines
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of Pneumococcal Vaccines in This Report
1.2 Commercial Types of Pneumococcal Vaccines
1.2.1 PPSV
1.2.2 PCV 7/13
1.2.3 PCV
1.3 Downstream Application of Pneumococcal Vaccines
1.3.1 For Infants
1.3.2 For Children (2-10)
1.3.3 For Person (10-64)
1.3.4 For The Old (?65)
1.4 Development History of Pneumococcal Vaccines
1.5 Market Status and Trend of Pneumococcal Vaccines 2013-2023
1.5.1 Global Pneumococcal Vaccines Market Status and Trend 2013-2023
1.5.2 Regional Pneumococcal Vaccines Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Pneumococcal Vaccines 2013-2017
2.2 Sales Market of Pneumococcal Vaccines by Regions
2.2.1 Sales Volume of Pneumococcal Vaccines by Regions
2.2.2 Sales Value of Pneumococcal Vaccines by Regions
2.3 Production Market of Pneumococcal Vaccines by Regions
2.4 Global Market Forecast of Pneumococcal Vaccines 2018-2023
2.4.1 Global Market Forecast of Pneumococcal Vaccines 2018-2023
2.4.2 Market Forecast of Pneumococcal Vaccines by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of Pneumococcal Vaccines by Types
3.2 Sales Value of Pneumococcal Vaccines by Types
3.3 Market Forecast of Pneumococcal Vaccines by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of Pneumococcal Vaccines by Downstream Industry
4.2 Global Market Forecast of Pneumococcal Vaccines by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America Pneumococcal Vaccines Market Status by Countries
5.1.1 North America Pneumococcal Vaccines Sales by Countries (2013-2017)
5.1.2 North America Pneumococcal Vaccines Revenue by Countries (2013-2017)
5.1.3 United States Pneumococcal Vaccines Market Status (2013-2017)
5.1.4 Canada Pneumococcal Vaccines Market Status (2013-2017)
5.1.5 Mexico Pneumococcal Vaccines Market Status (2013-2017)
5.2 North America Pneumococcal Vaccines Market Status by Manufacturers
5.3 North America Pneumococcal Vaccines Market Status by Type (2013-2017)
5.3.1 North America Pneumococcal Vaccines Sales by Type (2013-2017)
5.3.2 North America Pneumococcal Vaccines Revenue by Type (2013-2017)
5.4 North America Pneumococcal Vaccines Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe Pneumococcal Vaccines Market Status by Countries
6.1.1 Europe Pneumococcal Vaccines Sales by Countries (2013-2017)
6.1.2 Europe Pneumococcal Vaccines Revenue by Countries (2013-2017)
6.1.3 Germany Pneumococcal Vaccines Market Status (2013-2017)
6.1.4 UK Pneumococcal Vaccines Market Status (2013-2017)
6.1.5 France Pneumococcal Vaccines Market Status (2013-2017)
6.1.6 Italy Pneumococcal Vaccines Market Status (2013-2017)
6.1.7 Russia Pneumococcal Vaccines Market Status (2013-2017)
6.1.8 Spain Pneumococcal Vaccines Market Status (2013-2017)
6.1.9 Benelux Pneumococcal Vaccines Market Status (2013-2017)
6.2 Europe Pneumococcal Vaccines Market Status by Manufacturers
6.3 Europe Pneumococcal Vaccines Market Status by Type (2013-2017)
6.3.1 Europe Pneumococcal Vaccines Sales by Type (2013-2017)
6.3.2 Europe Pneumococcal Vaccines Revenue by Type (2013-2017)
6.4 Europe Pneumococcal Vaccines Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific Pneumococcal Vaccines Market Status by Countries
7.1.1 Asia Pacific Pneumococcal Vaccines Sales by Countries (2013-2017)
7.1.2 Asia Pacific Pneumococcal Vaccines Revenue by Countries (2013-2017)
7.1.3 China Pneumococcal Vaccines Market Status (2013-2017)
7.1.4 Japan Pneumococcal Vaccines Market Status (2013-2017)
7.1.5 India Pneumococcal Vaccines Market Status (2013-2017)
7.1.6 Southeast Asia Pneumococcal Vaccines Market Status (2013-2017)
7.1.7 Australia Pneumococcal Vaccines Market Status (2013-2017)
7.2 Asia Pacific Pneumococcal Vaccines Market Status by Manufacturers
7.3 Asia Pacific Pneumococcal Vaccines Market Status by Type (2013-2017)
7.3.1 Asia Pacific Pneumococcal Vaccines Sales by Type (2013-2017)
7.3.2 Asia Pacific Pneumococcal Vaccines Revenue by Type (2013-2017)
7.4 Asia Pacific Pneumococcal Vaccines Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America Pneumococcal Vaccines Market Status by Countries
8.1.1 Latin America Pneumococcal Vaccines Sales by Countries (2013-2017)
8.1.2 Latin America Pneumococcal Vaccines Revenue by Countries (2013-2017)
8.1.3 Brazil Pneumococcal Vaccines Market Status (2013-2017)
8.1.4 Argentina Pneumococcal Vaccines Market Status (2013-2017)
8.1.5 Colombia Pneumococcal Vaccines Market Status (2013-2017)
8.2 Latin America Pneumococcal Vaccines Market Status by Manufacturers
8.3 Latin America Pneumococcal Vaccines Market Status by Type (2013-2017)
8.3.1 Latin America Pneumococcal Vaccines Sales by Type (2013-2017)
8.3.2 Latin America Pneumococcal Vaccines Revenue by Type (2013-2017)
8.4 Latin America Pneumococcal Vaccines Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa Pneumococcal Vaccines Market Status by Countries
9.1.1 Middle East and Africa Pneumococcal Vaccines Sales by Countries (2013-2017)
9.1.2 Middle East and Africa Pneumococcal Vaccines Revenue by Countries (2013-2017)
9.1.3 Middle East Pneumococcal Vaccines Market Status (2013-2017)
9.1.4 Africa Pneumococcal Vaccines Market Status (2013-2017)
9.2 Middle East and Africa Pneumococcal Vaccines Market Status by Manufacturers
9.3 Middle East and Africa Pneumococcal Vaccines Market Status by Type (2013-2017)
9.3.1 Middle East and Africa Pneumococcal Vaccines Sales by Type (2013-2017)
9.3.2 Middle East and Africa Pneumococcal Vaccines Revenue by Type (2013-2017)
9.4 Middle East and Africa Pneumococcal Vaccines Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF PNEUMOCOCCAL VACCINES
10.1 Global Economy Situation and Trend Overview
10.2 Pneumococcal Vaccines Downstream Industry Situation and Trend Overview
CHAPTER 11 PNEUMOCOCCAL VACCINES MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of Pneumococcal Vaccines by Major Manufacturers
11.2 Production Value of Pneumococcal Vaccines by Major Manufacturers
11.3 Basic Information of Pneumococcal Vaccines by Major Manufacturers
11.3.1 Headquarters Location and Established Time of Pneumococcal Vaccines Major Manufacturer
11.3.2 Employees and Revenue Level of Pneumococcal Vaccines Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 PNEUMOCOCCAL VACCINES MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Pfizer
12.1.1 Company profile
12.1.2 Representative Pneumococcal Vaccines Product
12.1.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Pfizer
12.2 Sanofi
12.2.1 Company profile
12.2.2 Representative Pneumococcal Vaccines Product
12.2.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Sanofi
12.3 GSK
12.3.1 Company profile
12.3.2 Representative Pneumococcal Vaccines Product
12.3.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of GSK
12.4 Merck
12.4.1 Company profile
12.4.2 Representative Pneumococcal Vaccines Product
12.4.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Merck
12.5 Eli Lilly
12.5.1 Company profile
12.5.2 Representative Pneumococcal Vaccines Product
12.5.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Eli Lilly
12.6 AstraZeneca
12.6.1 Company profile
12.6.2 Representative Pneumococcal Vaccines Product
12.6.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of AstraZeneca
12.7 Abera
12.7.1 Company profile
12.7.2 Representative Pneumococcal Vaccines Product
12.7.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Abera
12.8 S K Chemicals
12.8.1 Company profile
12.8.2 Representative Pneumococcal Vaccines Product
12.8.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of S K Chemicals
12.9 Beijing Minhai Biotechnology
12.9.1 Company profile
12.9.2 Representative Pneumococcal Vaccines Product
12.9.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Beijing Minhai Biotechnology
12.10 Baxter
12.10.1 Company profile
12.10.2 Representative Pneumococcal Vaccines Product
12.10.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Baxter
12.11 Biken
12.11.1 Company profile
12.11.2 Representative Pneumococcal Vaccines Product
12.11.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Biken
12.12 Celgene Corporation
12.12.1 Company profile
12.12.2 Representative Pneumococcal Vaccines Product
12.12.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Celgene Corporation
12.13 Panacea Biotec
12.13.1 Company profile
12.13.2 Representative Pneumococcal Vaccines Product
12.13.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Panacea Biotec
12.14 Serum Institute of India
12.14.1 Company profile
12.14.2 Representative Pneumococcal Vaccines Product
12.14.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Serum Institute of India
12.15 Genentech
12.15.1 Company profile
12.15.2 Representative Pneumococcal Vaccines Product
12.15.3 Pneumococcal Vaccines Sales, Revenue, Price and Gross Margin of Genentech
12.16 Genocea Biosciences
12.17 ImmunoBiology
12.18 Lupin
12.19 Nuron Biotech
12.20 Biogen
12.21 Valneva Austria
12.22 Sinovac
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF PNEUMOCOCCAL VACCINES
13.1 Industry Chain of Pneumococcal Vaccines
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF PNEUMOCOCCAL VACCINES
14.1 Cost Structure Analysis of Pneumococcal Vaccines
14.2 Raw Materials Cost Analysis of Pneumococcal Vaccines
14.3 Labor Cost Analysis of Pneumococcal Vaccines
14.4 Manufacturing Expenses Analysis of Pneumococcal Vaccines
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
